Literature DB >> 1407249

Epidemiology of myasthenia gravis in the province of Trento (northern Italy).

G Ferrari1, M G Lovaste.   

Abstract

The epidemiology of myasthenia gravis (MG) was studied in the province of Trento (northern Italy) among 444,879 inhabitants. On prevalence day (December 31, 1990) the crude rate was 82.9 per million population: 113 for females and 50.7 for males. The incidence rate was 7.4 per million per year: 10.8 for females and 4.6 for males. Over the same observation period (1981-1990), we calculated a death rate of 1.12 per million population per year. MG predominates in females. Nevertheless, we observed some differences related to age and to presence of thymoma, and our data supports the recognition of three types of MG: (1) predominating in females with a peak frequency at about 20-29 years; (2) affecting both males and females, with a frequency increasing with age, and (3) associated with thymoma.

Entities:  

Mesh:

Year:  1992        PMID: 1407249     DOI: 10.1159/000110923

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  7 in total

Review 1.  A systematic review of population based epidemiological studies in Myasthenia Gravis.

Authors:  Aisling S Carr; Chris R Cardwell; Peter O McCarron; John McConville
Journal:  BMC Neurol       Date:  2010-06-18       Impact factor: 2.474

2.  Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.

Authors:  N P Robertson; J Deans; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

3.  Epidemiological study of myasthenia gravis in the province of Reggio Emilia, Italy.

Authors:  D Guidetti; R Sabadini; M Bondavalli; S Cavalletti; M Lodesani; R Mantegazza; V Cosi; F Solime
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

4.  Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.

Authors:  Hakan Cetin; Gerhard Fülöp; Heidemarie Zach; Eduard Auff; Fritz Zimprich
Journal:  Wien Klin Wochenschr       Date:  2012-11-06       Impact factor: 1.704

5.  Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database.

Authors:  Su Yeon Park; Jin Yong Lee; Nam Gu Lim; Yoon Ho Hong
Journal:  J Clin Neurol       Date:  2016-05-10       Impact factor: 3.077

6.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

7.  Incidence of thymoma in myasthenia gravis: a systematic review.

Authors:  Zhi-Feng Mao; Xue-An Mo; Chao Qin; Yong-Rong Lai; Maree L Hackett
Journal:  J Clin Neurol       Date:  2012-09-27       Impact factor: 3.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.